DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Merck & Co., Inc. (NYSE: MRK)



company name or ticker
Company Photos
(Click to zoom)

The Real Source Of A Santa Claus Rally

Weekly Pharmaceutical Notes: Pfizer, Bristol-Myers Squibb And Roche

Noteworthy ETF Outflows: VTV, MRK, WMT, BMY

Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When

Interesting MRK Put And Call Options For February 2015

This Cancer Drug War Is Just Getting Started

The FDA approves Bristol-Myers Squibb's Opdivo, pitting it against Merck's Keytruda that was approved earlier this year.

Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog

Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog

FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutica

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical